Given a number of molecular candidates to become medicines, determine which ones to try first.

The huge number of candidates against the very high cost of researching any one of them form a formidable bottleneck in the drug discovery world.

IconixPharmaceutical uses Genomics to integrate chemical and genetic data ("ChemoGenomics") to attempt to predict toxicity and efficacy.